期刊文献+

双(α-呋喃甲酸)氧钒对胰岛素抵抗3T3-L1脂肪细胞糖摄取的影响 被引量:3

Effects of bis (α-furancarboxylato) oxovanadium (IV) on the glucose uptake in normal and insulin-resistant 3T3-L1 adipocytes
下载PDF
导出
摘要 目的探讨新型的有机羧酸氧钒配合物双(α-呋哺甲酸)氧钒(BFOV)对正常及胰岛素抵抗的3T3-L1脂肪细胞糖摄取的影响。方法采用地塞米松诱导313-L1脂肪细胞建立胰岛素抵抗的细胞模型,研究双(d-呋喃甲酸)氧钒对正常及胰岛素抵抗313-L1脂肪细胞葡萄糖消耗的影响。结果双(d-呋喃甲酸)氧钒(2.5μmol·L^-1 - 40μmol·L^-1)对正常的313-L1脂肪细胞仅有增加葡萄糖消耗量的趋势,与空白对照组比较,差异无显著性;但能明显增加地塞米松诱导的胰岛素抵抗313-L1脂肪细胞的葡萄糖消耗量,改善模型细胞的胰岛素抵抗状态。结论双(d-呋喃甲酸)氧钒能促进胰岛素抵抗脂肪细胞的葡萄糖摄取,改善胰岛素抵抗状态。 Aim To investigate the effects of bis [(α-furancarboxylato) oxovanadium (IV) , BFOV] on the glucose uptake in normal and insulin-resistant 3T3-L1 adipocytes. Method Fully differentiated 3T3-L1 adipocytes were treated with dexamethasone to induce insulin resistance. Effects of bis (α-furancarboxylato) oxovanadium (IV) on the glucose uptake in normal and insuhn-resistant adipocytes were estimated by the chan-ges of glucose consumption in the medium measured by the glucose oxidase method. Results BFOV (2.5-40 )μmol·L^-1) produced the tendency of increasing the glucose consumption in normal cells, compared with untreated control cells (P〉0.05 ). However, BFOV markedly enhanced the glucose consumption in insulinresistant 3T3-L1 adipocytes, resulting in the improvement of insulin resistance induced by dexamethasone. Conclusion BFOV increased the glucose uptake in insulin-resistant adipocytes, suggesting the improvement of insulin resistance.
出处 《中国药理学通报》 CAS CSCD 北大核心 2008年第7期902-905,共4页 Chinese Pharmacological Bulletin
基金 国家自然科学基金资助项目(No30260118) 云南省应用基础研究计划重点资助项目(No2006C009Z)
关键词 双(Α-呋喃甲酸)氧钒 313-L1脂肪细胞 地塞米松 胰岛素抵抗 葡萄糖消耗 bis (α-furancarboxylato) oxovanadium(IV) 333-L1 adipocytes dexamethasone insulin resistance glucose consumption
  • 相关文献

参考文献15

  • 1Cam M C,Brownsey R W, McNeill J H, Mechanisms of vanadium action : insulin-mimetic or insulin-enhancing agent [ J ] ? Can J Physiol Pharmacol,2000,78 ( 10 ) :829 - 47.
  • 2Srivastava A K,Mehdi M Z. Insulino-mlmetic and anti-diabetlc effects of vanadium compounds[J]. Diabetic Med,2004,22:2 - 13.
  • 3谢明进,刘伟平,李玲,陈植和.双(α-呋喃甲酸)氧钒的合成和抗糖尿病活性研究[J].化学学报,2002,60(5):892-896. 被引量:16
  • 4高丽辉,谢明进,李玲1,刘伟平,李艳蓉,陈植和.双(α-呋喃甲酸)氧钒对糖尿病大鼠血糖的调节作用[J].药学学报,2005,40(6):496-500. 被引量:7
  • 5Xie M J, Gao L H, Li Let al. A new orally active antidiabetic vanadyl complex-bis (α-furancarboxylato) oxovanadium ( IV ) [ J ]. J Inorg Biochem,2005,99 (2) :546 - 51.
  • 6Gao L H,Liu W P,Wang B L,et al. Effects of bis( alpha-furancar- bexylato) oxovanadium(IV) on non-diabetic and streptozotocin-diabetic rats[ J]. Clin Chim Acta ,2006,368 : 173 - 8.
  • 7Niu Y F, Liu W P, Tian C F, et al. Effects of bis ( α-furancarboxylato) oxovanadium(IV) on glucose metabolism in fat-fed/streptozotocin diabetic rats[ J]. Eur J Pharmacol,2007,572(2-3) :213 - 9.
  • 8Grunfeld C, Baird K, Van Obberghen E, et al. Glucocorticoid-induced insulin resistance in vitro: evidence for both receptor and postreceptor defects [ J ]. Endocrinology, 1981,109 (5) : 1723 - 30.
  • 9Anil Kumar K L, Marita A R. Troglitazone prevents and reverses dexamethasone induced insulin resistance on glycogen synthesis in 3T3 adipocyte[ J], Br J Parmacol,2000,130(2 ) :351 - 8.
  • 10刘莉,王佑民,丁振兴,杨明功.Adiponutrin mRNA在分化成熟的3T3-L1脂肪细胞中的表达[J].中国药理学通报,2006,22(12):1535-1535. 被引量:1

二级参考文献38

  • 1Gurnell M,Savage DB,Chatterjee VK et al.The metabolic syndrome:Peroxisome proliferator-activated receptor gamma and its therapeutic modulation[J].J Clin Endocrinol Metab,2003,88(6):2412-21.
  • 2Tadayyon M,Smith SA.Insulin sensitisation in the treatment of Type diabetes[J].Expert Opin Investig Drugs,2003,12(3):307-24.
  • 3Melin B,Cherqui G,Blivet MJ et al.Dual effect of metformin in cultured rat hepatocytes:potentiation of insulin action and prevention of insulin-induced insulin resistance[J].Metabolism,1990,39:1089.
  • 4Arakawa K,Ishihara T,Auto M et al.Action of novel antidiabetic thiazolidinedione,T-174,in animals of non-insulin-dependent diabetes mellitus(NIDDM) and in cultured muscle cells[J].Br J Pharmacol,1998,125:429-36.
  • 5Senn JJ,Klover PJ,Nowak IA et al.Interleukin-6 induces cellular insulin resistance in hepatocytes[J].Diabetes,2002,51(12):3391-9
  • 6Bernal MC,Weng S,Finck BN et al.Dexamethasone induction of hypertension and diabetes is PPAR-alpha dependent in LDL receptor-null mice[J].Nat Med,2003,9(8):1069-75.
  • 7Camp HS.Thiazolidinediones in diabetes:Current status and future outlook[J].Curr Opin Investig Drugs,2003,4(4):406-11.
  • 8Santure M,Pitre M,Nadeau A et al.Effect of troglitazone on vascular and glucose metabolic actions of insulin in high-sucrose-fed rats[J].Metabolism,2003,52(8):978-86.
  • 9Julia A,Barman B,Greg L.Rosiglitazone[J].Drugs,1999,57:921-7.
  • 10Nielsen FH. Metal Ions in Biological Systems: Vanadium and Its Role in Life [M]. New York: Marcel Dekker, 1995.31543.

共引文献48

同被引文献25

  • 1陈静,郭丽娜,郑成.二氢杨梅素对糖耐量异常大鼠氧化和非酶糖基化的影响[J].吉林大学学报(医学版),2008,34(6):994-997. 被引量:3
  • 2任晋玮,万祺,栾新慧,单俊杰.天然化合物治疗糖尿病的研究进展[J].军事医学科学院院刊,2006,30(4):375-378. 被引量:2
  • 3Zhu H,Jia Z,Strobl JS.Potent induction of total cellular and mitochondrial antioxidants and phase 2 enzymes by cruciferous sulforaphane in rat aortic smooth muscle cells:cytoprotection against oxidative and electrophilic stress.Cardiovasc Toxicol.2008;8(3):115-125.
  • 4Kahn SE.The relative contributions of insulin resistance and beta2 cell dysfunction to the pathophysiology of type 2 diabetes.Diabetologia.2003;46(1):3219.
  • 5Evans JL,Goldfine ID,Maddux BA,et al.Oxidative stress and stress activated signaling pathways:a unifying hypothesis of type 2 diabetes.Endocr Rev.2002;23(5):599-622.
  • 6Alan R,Saltiel C,Roonald K.Insulin signaling and the regulation of glucose and lipid metabolism.Nature.2001;414(6865):799-806.
  • 7Krentz AJ,Bailey CJ.Oral antidiabetic agents:current role in type 2 diabetes mellitus.Drugs,2005;65(3):385-411.
  • 8Hayden MR,Sowers JR.Redox imbalance in diabetes.Antioxid redox signal,2007;9(7):865-867.
  • 9Li WL,Zheng HC,Bukuru J,et al.Natural medicines used in the tradi-tional Chinese medical system for therapy of diabetes mellitus.J Ethnophar-macol,2004;92:1-21.
  • 10Tan MJ,Ye JM,Turner N,et al.Antidiabetic avtivities of triterpenoids isolation from bitter melon associated with activation of the AMPK pathway.Chem Biol,2008;15:263-273.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部